期刊文献+

腰椎间盘突出症实施临床路径治疗的医疗费用控制及效果评价 被引量:22

Clinical pathway to treat lumbar disc herniation:Cost control and effective evaluation
在线阅读 下载PDF
导出
摘要 背景:临床路径是美国和欧洲医院应用在临床医疗服务中用来控制医疗费用的一种手段。目的:探讨实施临床路径的医疗费用控制效果。方法:以卫生部制定的腰椎间盘突出症手术医疗临床路径为基础,结合医院自身实际情况设计相应临床路径,对同类手术的临床路径和非临床路径患者医疗费用进行对照研究,通过医院医疗费用信息系统提取相关数据并建立数据库,并对各组数据进行相关统计学分析。结果与结论:与非临床路径患者比较,进入临床路径患者总住院天数、手术前后住院天数、总住院费用、手术前后及手术日住院费均显著减少(P<0.05)。说明临床路径可缩短患者住院时间,降低住院费用,规范诊疗行为,节约卫生资源。 BACKGROUND:Clinical pathway is widely used in U.S.and European hospitals as a successful method to control medical costs.OBJECTIVE:To analyze the effects of controlling medical costs after implementation of clinical pathway.METHODS:The corresponding clinical pathway was designed based on the clinical pathway of Ministry of Health and hospital practice,and a comparison study was peformed in the medical costs of the clinical pathway group and the control group in the way of setting up database through the hospital information system and statistically analyzing the related data.RESULTS AND CONCLUSION:Compared to the control group,the total length of the hospital stay,the length of the hospital stay before and after surgery,the total medical costs,the surgery medical costs and medical care costs before and after surgery in hospital were declined in patients who took clinical pathways(P 0.05).It means that the clinical pathway practice can decline the length of hospital stay,reduce medical costs,standardize the diagnosis and treatment behavior and conserve the health resources.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2011年第39期7399-7402,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
  • 相关文献

参考文献31

  • 1Olsen CA.Building critical pathways for a hospital-based home care program.Outreach.1993;14(3):1-3.
  • 2Spath PL.Critical paths:a tool for clinical process management.JAHIMA.1993;64(3):48-58.
  • 3Hoioweiko M.What are you greatest malpractice risk.Med Economics.1992;69(15):140-144.
  • 4Vanhaecht K,Bollmann M,Bower K,et al.Prevalence and use of clinical pathways in 23 countries-an international survey by the European pathway association.J Int Care Pathways.2006;(9):1-7.
  • 5He L,Du XL.Zhongguo Zuzhi Gongcheng Yanjiu yu Linchuang Kangfu.2007;11(40):8173-8177.
  • 6何林,杜小丽.循证医学临床实践指南检索[J].中国组织工程研究与临床康复,2007,11(40):8173-8177. 被引量:23
  • 7Holoweiko M.What are your greatest malpractice risk.Med Economics.1992;69(15):140-I44.
  • 8Dong J.Zhongguo Yiyuan Guanli.2003;23(6):11-12.
  • 9董军.临床路径的特点与应用[J].中国医院管理,2003,23(6):11-12. 被引量:95
  • 10Zeng BT,Xu TT,Chen XY,et al.Zhongguo Yiyuan Guanli.2006; 26(7):40-42.

二级参考文献62

共引文献596

同被引文献162

引证文献22

二级引证文献131

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部